Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v3-EN
Language English English
Date Updated 2019-10-01 2019-07-31
Drug Identification Number 02307871 02307871
Brand name PMS-PANTOPRAZOLE PMS-PANTOPRAZOLE
Common or Proper name PANTOPRAZOLE PANTOPRAZOLE
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients PANTOPRAZOLE PANTOPRAZOLE
Strength(s) 40MG 40MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 500 500
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-09-30 2019-08-12
Actual start date
Estimated end date 2020-04-22 2020-04-01
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments